Newsroom
Sorted by: Latest
-
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced pivotal clinical validation results of AlloHeme™, a non-invasive, next‑generation sequencing (NGS)–based, and artificial intelligence (AI)-powered monitoring test designed to predict relapse in...
-
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics launches PanTracer Pro, designed to help clinicians navigate complex molecular testing and support informed solid tumor decisions....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 11.02.2026 CHPS.LN IE000KXTLDE2 700,002.00 USD 25,539,153.97 36.484 ...
-
FiscalNote Announces Major Expansion Into Political Prediction Markets
WASHINGTON--(BUSINESS WIRE)--FiscalNote Announces Major Expansion Into Political Prediction Markets...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 11.02.2026 MISL.LN IE000NVDQXE1 3,250,002.00 USD 114,686,413.71 35.288 ...
-
AXA and Planet Partner to Revolutionize Disaster Management and Prevention
BERLIN--(BUSINESS WIRE)--Planet Labs GmbH, a leading provider of daily data and insights about change on Earth, today announced a strategic partnership with AXA Digital Commercial Platform (AXA DCP), an all-in-one risk management system, to provide high-frequency satellite imagery to monitor, predict, and respond to natural disasters in near-real-time. Through this partnership, AXA DCP will integrate data from Planet’s high resolution and medium resolution satellites, and high-frequency Basemap...
-
N-able Empower 2026 to Take Place in Fort Lauderdale
BURLINGTON, Mass.--(BUSINESS WIRE)--N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering business resilience, today announced Empower 2026 will take place in Fort Lauderdale from April 13-15, 2026, at the Omni Hotel. As AI continues to fuel stronger and smarter attacks, building business resilience is an ongoing process. This event will shine a spotlight on what’s working, what’s falling short, and what’s on the horizon in cybersecurity. Over three dynamic days, technology leade...
-
Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1™, a Breakthrough Wearable Device for Essential Tremor
BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. This clearance is supported by data from two clinical studies: a randomized, sham-controlled trial and a 90-day home-use study. Together, these studies demonstrated consistent improvements in tremor severity and functional tasks, showcasing the device's ability to aid in daily activiti...
-
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025. Frank H. Laukien, Bruker’s President and CEO, commented: “At the conclusion of a difficult year 2025, with headwinds from academic funding, tariffs and currencies, we are pleased that in the fourth quarter we delivered revenues ahead of our expectations. A recovery in biopharma and industrial research markets in the second h...
-
Element 1® Corp. and Aurosi Precision Co. Ltd. Sign Memorandum of Understanding to Advance Methanol-to-Hydrogen Power Solutions for Taiwan Data Center Project
BEND, Ore.--(BUSINESS WIRE)--Element 1® Corp. (“e1”), an Oregon-based leader in methanol-to-hydrogen generation technology, today announced the signing of a Memorandum of Understanding (MOU) with Aurosi Precision Co., Ltd. (“Aurosi”), a Taiwan-based manufacturer specializing in battery energy storage systems and hydrogen-powered product development. The agreement outlines a collaboration to support a major off-grid data center power project in Taiwan. Under the MOU, Aurosi intends to procure e1...